Skip to content
You are not logged in |Login  

LEADER 00000cam a2200649Ia 4500 
001    ocn801422000 
003    OCoLC 
005    20160527040714.1 
006    m     o  d         
007    cr cnu|||||||| 
008    120720s2012    enka    ob    001 0 eng   
019    843640702 
020    9781849735346|q(electronic book) 
020    1849735344|q(electronic book) 
020    |z9781849734134|q(print) 
020    |z1849734135|q(print) 
035    (OCoLC)801422000|z(OCoLC)843640702 
040    AU@|beng|epn|cAU@|dUIU|dUKRSC|dMYG|dOCLCQ|dYDXCP|dN$T
       |dDEBSZ|dMHW|dOCLCQ 
049    RIDW 
050  4 RM405|b.A58 2012eb 
072  7 MED|x071000|2bisacsh 
082 04 615.7/94|223 
090    RM405|b.A58 2012eb 
245 00 Anti-inflammatory drug discovery /|cedited by Jeremy I. 
       Levin, Stefan Laufer. 
264  1 Cambridge, U.K. :|bRoyal Society of Chemistry,|c[2012] 
264  4 |c©2012 
300    1 online resource (xv, 528 pages) :|billustrations (some 
       color). 
336    text|btxt|2rdacontent 
337    computer|bc|2rdamedia 
338    online resource|bcr|2rdacarrier 
340    |gpolychrome|2rdacc 
347    text file|2rdaft 
490 1  RSC drug discovery series,|x2041-3203 ;|v26 
504    Includes bibliographical references and index. 
520    Anti-Inflammatory Drug Discovery provides a comprehensive 
       review of recent medicinal chemistry approaches to a 
       variety of important therapeutic targets and provides a 
       key reference for those interested in the prosecution of 
       modern drug discovery programs directed at anti-
       inflammatory mechanisms of action. The editors, with 
       extensive experience in this field, have selected key 
       thought-leaders who will bring their experience to the 
       medicinal chemistry literature for each target, ranging 
       from components of the arachadonic acid cascade, to 
       kinases, GPCRs, sphingolipids and others, to summarize its
       background biology and detail new insights, major advances
       and issues related to bringing new anti-inflammatory 
       therapies to market. Consisting of five main sections key 
       targets covered will include the AA Cascade: mPGES1, cPLA2,
       Leukotriene A4 Hydrolase, CRTH2; Kinases: P38/PDE4, MAPKAP
       Kinase 2 (MK2), Syk Kinase Inhibitors, Jak Kinases, IKK, 
       Bruton's Tyrosine Kinase; GPCRs: CCR1, CCR2 Antagonists, 
       CB2 Agonists; Sphingolipids: S1P1 Receptor Agonists, 
       Sphingosine Lyase and Sphingosine Kinase 1 and a final 
       miscellaneous section that looks at Non-Steroidal 
       Dissociated Glucocorticoid Receptor Agonists. The book 
       will be essential reading for pharmacologists, medicinal 
       chemists and pharmaceutical scientists working in industry
       and academia."--|cProvided by publisher. 
588 0  Print version record. 
590    eBooks on EBSCOhost|bEBSCO eBook Subscription Academic 
       Collection - North America 
650  0 Anti-inflammatory agents|0https://id.loc.gov/authorities/
       subjects/sh85005615|xResearch.|0https://id.loc.gov/
       authorities/subjects/sh2002006576 
650  0 Anti-inflammatory agents|0https://id.loc.gov/authorities/
       subjects/sh85005615|xTherapeutic use|0https://id.loc.gov/
       authorities/subjects/sh2001008985|xTechnological 
       innovations.|0https://id.loc.gov/authorities/subjects/
       sh2001009095 
650  0 Inflammation|0https://id.loc.gov/authorities/subjects/
       sh85066108|xTreatment|0https://id.loc.gov/authorities/
       subjects/sh99005040|xResearch.|0https://id.loc.gov/
       authorities/subjects/sh2002006576 
650  7 Anti-inflammatory agents.|2fast|0https://id.worldcat.org/
       fast/810354 
650  7 Research.|2fast|0https://id.worldcat.org/fast/1095153 
650  7 Technological innovations.|2fast|0https://id.worldcat.org/
       fast/1145002 
650  7 Inflammation.|2fast|0https://id.worldcat.org/fast/972432 
655  0 Electronic books. 
655  4 Electronic books. 
700 1  Levin, Jeremy I.|0https://id.loc.gov/authorities/names/
       n2012189799 
700 1  Laufer, Stefan.|0https://id.loc.gov/authorities/names/
       n2003130085 
776 08 |iPrint version:|tAnti-inflammatory drug discovery
       |z9781849734134|w(OCoLC)794035667|w(OCoLC)794035667 
830  0 RSC drug discovery series ;|0https://id.loc.gov/
       authorities/names/no2010092643|v26.|x2041-3203 
856 40 |uhttps://rider.idm.oclc.org/login?url=http://
       search.ebscohost.com/login.aspx?direct=true&scope=site&
       db=nlebk&AN=519389|zOnline eBook. Access restricted to 
       current Rider University students, faculty, and staff. 
856 42 |3Instructions for reading/downloading this eBook|uhttp://
       guides.rider.edu/ebooks/ebsco 
901    MARCIVE 20231220 
948    |d20160607|cEBSCO|tebscoebooksacademic|lridw 
994    92|bRID